Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
5.45M
-
Shares change
-
-56.2K
-
Total reported value, excl. options
-
$38.3M
-
Value change
-
-$395K
-
Number of buys
-
13
-
Number of sells
-
-10
-
Price
-
$7.00
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q2 2017
35 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q2 2017.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.45M shares
of 15M outstanding shares and own 36.41% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (1.11M shares), ARIEL INVESTMENTS, LLC (976K shares), DIMENSIONAL FUND ADVISORS LP (866K shares), BlackRock Inc. (400K shares), VANGUARD GROUP INC (299K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (294K shares), RENAISSANCE TECHNOLOGIES LLC (291K shares), NEW YORK STATE COMMON RETIREMENT FUND (269K shares), JW Asset Management, LLC (264K shares), and ACADIAN ASSET MANAGEMENT LLC (130K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.